Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway - Test2 - elhamkhani - TriplyDB

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

http://www.wikidata.org/entity/Q24301518

about

The interaction of angiocidin with tissue transglutaminase Transglutaminase is a tumor cell and cancer stem cell survival factor Rottlerin and cancer: novel evidence and mechanisms The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms Cellular functions of tissue transglutaminase Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2 Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells.EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation.Transglutaminase regulation of cell function.Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states Regulation of endothelial cell inflammation and lung polymorphonuclear lymphocyte infiltration by transglutaminase 2.The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.NF-kappaB and cancer: how intimate is this relationship Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.The metastatic tumor antigen 1-transglutaminase-2 pathway is involved in self-limitation of monosodium urate crystal-induced inflammation by upregulating TGF-β1 Extracellular TG2: emerging functions and regulation.Transglutaminase 2: a molecular Swiss army knife.Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease Transglutaminase 2 inhibitors and their therapeutic role in disease states.Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: a retrospective study Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ light chain enhancer of activated B cells (NFκB) signaling controls basal and DNA damage-induced transglutaminase 2 expression.

P2860

0e37b6761473e78e383a89945026e99404947e00 34fea8f7e49374bcbd791b1533384aad1d921a2e 90cb08f1c961ef7c3889736896fa0ca8131e7b18

P248

Q24318943-F85F191B-9D2E-4492-875E-A0A501C0E1F1 Q26799862-C73B99AE-7550-4E93-9F55-18B5BE0D5364 Q27000504-7EE8AA14-E735-46E1-AE41-14F7EFA7C389 Q28066752-29F52A0C-DF0D-46DE-98DE-25B1E8D98CC1 Q28260600-12124E74-A277-47CF-9EC4-CD39E1C88427 Q28261578-290CAFB0-BCAC-4F7D-8C04-3164594ABCAC Q28388105-18C8ECBD-AE79-48BA-AF6B-AE6B8319466F Q28475746-2978D8A8-F516-4C0F-9086-9E11C2674952 Q28540004-80270AA3-0CC5-49D6-8125-204AD189ADB2 Q28550149-CAD2E83B-74E6-4DD3-A472-7AB3F0D2A4A4 Q30483685-66814681-E5E3-4FA6-9E33-7F05CF262E2E Q30499127-A6316D9D-C5EF-4220-A8AA-532306E32BFF Q33289840-A0444C1F-297E-4020-9DDF-35B07B481CF9 Q33667547-ECE5DFEF-2B04-475D-80C0-BF4E5D0FD5B6 Q33707936-17668D9D-B883-4ABF-8C62-6974EE7CDCA8 Q33719099-76FC1DA8-B3CD-4EF7-BD27-F74367F71599 Q33730021-7E36544F-D2DA-477B-B472-36225C32566E Q34031863-09D33B6B-D54E-4AED-9C57-0AD9197FC12A Q34079481-C7351542-FA2B-4710-A642-A0BE7E8287AE Q34109699-FA46C633-9BC4-4035-9AEC-25A7678FAF8A Q34154917-897331D4-EEF5-4BB4-8C59-344919BBA6C1 Q34267466-7AA817EC-F528-4BFE-A1FC-2A004C11852E Q34324624-F43458A0-A1B0-45B7-A096-45CA4C98660B Q34489967-318B39F6-E330-49E0-867E-36FF141285C5 Q34517980-EA8DC8F2-2071-44EB-A5A9-B18FDE1BE11D Q34536570-EF19E0D3-1C26-4085-8240-ECA180E099B6 Q34596902-8FDC04D0-1C87-435C-AD19-78EC8D2834FF Q34994693-0C6FA5E7-23F3-42C8-94DA-EE298D37A1A2 Q35143597-A346224C-208E-4733-BF73-1AE64DD9AE5D Q35147626-EC04C308-1A6E-4346-80B3-39CB18ACC7ED Q35387117-F5A4ADD2-E1B0-4F76-969B-3CC7B8402668 Q35577299-6F39CE66-1F4C-45AF-B4E6-170CD94547EC Q35587161-3E212B3F-A4E4-4FF7-9B26-5F286706C302 Q35693361-A6F3902E-DC4C-4434-B575-76FADC793748 Q35849327-7A2DB06C-3112-4A78-A3D4-AC7C625F5524 Q35858675-5A8C6ACF-0695-4DBC-99A9-3456659D3009 Q35906658-4AAB1D91-82A2-44E2-A197-996054BCE9A3 Q35989247-450E2CEF-CBA2-4576-8F98-5FB116A3219D Q35996388-8948645F-1CF2-4192-A61B-A8BE4B8E4D0B Q36003028-94B3B0C4-9C8C-4342-A4D4-15B57411B788

P2860

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

http://www.wikidata.org/entity/Q24301518

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Overexpression of tissue trans ...... delineation of a novel pathway

@ast

Overexpression of tissue trans ...... delineation of a novel pathway

@en

Overexpression of tissue trans ...... delineation of a novel pathway

@en-gb

Overexpression of tissue trans ...... delineation of a novel pathway

@nl

type

label

Overexpression of tissue trans ...... delineation of a novel pathway

@ast

Overexpression of tissue trans ...... delineation of a novel pathway

@en

Overexpression of tissue trans ...... delineation of a novel pathway

@en-gb

Overexpression of tissue trans ...... delineation of a novel pathway

@nl

prefLabel

Overexpression of tissue trans ...... delineation of a novel pathway

@ast

Overexpression of tissue trans ...... delineation of a novel pathway

@en

Overexpression of tissue trans ...... delineation of a novel pathway

@en-gb

Overexpression of tissue trans ...... delineation of a novel pathway

@nl

P1433

Q24301518-B662379E-2790-40D6-997C-F116250CFE46

P1476

Q24301518-D84DB489-5640-4A58-8927-237AAC2537DB

P2093

Q24301518-120E3340-0763-4723-852B-0CC03D60F9C3

Q24301518-1B82E07C-B6F7-4493-A6EF-722B624409A1

Q24301518-3CCC1712-DE31-4A02-9A30-174EABFD5C02

Q24301518-4F8557A8-7538-4698-B32B-9288C42B61F0

Q24301518-77637551-9782-4ECD-B71E-310373D39AE9

Q24301518-CB816D25-585C-413E-A7A4-F190E5EE01DE

Q24301518-D6908ED1-52B0-4C41-98C0-D8139A807262

Q24301518-FAF7AE71-5CBA-4F8B-B126-6B633F3DE17D

P304

Q24301518-DABD5DA8-9775-4B13-9B12-922E3F76B89D

P31

Q24301518-191142D0-D5E1-4068-862C-E83BE60E99AC

P3181

Q24301518-9AF4180A-AE7A-49B6-BC43-D0468BC3A733

P356

Q24301518-42425EC9-598B-464D-884D-542B059CE797

P407

Q24301518-83CD5FB6-1F2C-4755-B3C3-E2FFC9EDD7EB

P433

Q24301518-9A3EC25E-8B20-40EF-A739-8DEB6E12013F

P478

Q24301518-7929912C-6604-4A94-8300-A4B358CC28C5

P50

Q24301518-A0EF7300-C9E4-44ED-9104-3DC660DEC59F

Q24301518-B336E55A-8591-4A11-B01A-C201D847B17A

P577

Q24301518-867EEAB2-9064-40D0-8581-3FB1C442019E

P698

Q24301518-0F0EA5BC-C4D2-4807-8383-0CAA192993BF

P921

Q24301518-1CCEB5A6-B22F-47F4-BD53-27EB5E928F81

Q24301518-B59DA944-15E9-4151-A0CB-1AD1B46F4D36

Q24301518-BC9FEFE8-67EB-477F-8647-5AD65DECEFE1

P3181

P356

0008-5472.CAN-06-1457

P1433

Cancer Research

P1476

Overexpression of tissue trans ...... delineation of a novel pathway

@en

P2093

Ajaikumar B Kunnumakkara

http://www.w3.org/2001/XMLSchema#string

Aman P Mann

http://www.w3.org/2001/XMLSchema#string

Amit Verma

http://www.w3.org/2001/XMLSchema#string

Bharat B Aggarwal

http://www.w3.org/2001/XMLSchema#string

Huamin Wang

http://www.w3.org/2001/XMLSchema#string

Jansina Y Fok

http://www.w3.org/2001/XMLSchema#string

Kapil Mehta

http://www.w3.org/2001/XMLSchema#string

Rakesh Kumar

http://www.w3.org/2001/XMLSchema#string

P304

8788-8795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3426941

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-06-1457

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Bramanandam Manavathi

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16951195

http://www.w3.org/2001/XMLSchema#string

P921

identical protein binding

NFKB inhibitor alpha